131 related articles for article (PubMed ID: 36314889)
1. Vitamin D Receptor Expression Is Significantly Decreased in Bone Metastases Compared to Matched Primary Breast Cancer Tumours.
Horas K; Abraham M; Ebert R; Weissenberger M; Maier GS; Jakob F; Rosenwald A; Rudert M
Cancer Invest; 2023 Feb; 41(2):133-143. PubMed ID: 36314889
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
3. Association of the vitamin D receptor genotype with bone metastases in breast cancer patients.
Schöndorf T; Eisberg C; Wassmer G; Warm M; Becker M; Rein DT; Göhring UJ
Oncology; 2003; 64(2):154-9. PubMed ID: 12566913
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein.
Ding P; Du X; Wan L; Zhao X; Zhang D; Huang Z; Cao G; Zhou X; Zheng Y; Cao Y
Oncol Res Treat; 2022; 45(4):166-177. PubMed ID: 34818655
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
6. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
[TBL] [Abstract][Full Text] [Related]
7. Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal Colonization.
Horas K; Zheng Y; Fong-Yee C; Macfarlane E; Manibo J; Chen Y; Qiao J; Gao M; Haydar N; McDonald MM; Croucher PI; Zhou H; Seibel MJ
J Bone Miner Res; 2019 Sep; 34(9):1721-1732. PubMed ID: 30995345
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
Keith ME; LaPorta E; Welsh J
Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
[TBL] [Abstract][Full Text] [Related]
9. Bone Metastases of Diverse Primary Origin Frequently Express the VDR (Vitamin D Receptor) and CYP24A1.
Seiler J; Ebert R; Rudert M; Herrmann M; Leich E; Weißenberger M; Horas K
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362766
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor expression in invasive breast tumors and breast cancer survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Rosendahl A; Manjer J
Breast Cancer Res; 2019 Jul; 21(1):84. PubMed ID: 31358030
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanism of Cancer Susceptibility Associated with Fok1 Single Nucleotide Polymorphism of VDR in Relation to Breast Cancer.
Raza S; Dhasmana A; Bhatt MLB; Lohani M; Arif JM
Asian Pac J Cancer Prev; 2019 Jan; 20(1):199-206. PubMed ID: 30678432
[TBL] [Abstract][Full Text] [Related]
13. Resistance of HBL100 human breast epithelial cells to vitamin D action.
Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation-related vitamin D receptor insensitivity in breast cancer.
Marik R; Fackler M; Gabrielson E; Zeiger MA; Sukumar S; Stearns V; Umbricht CB
Cancer Biol Ther; 2010 Jul; 10(1):44-53. PubMed ID: 20431345
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
16. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
18. Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort.
Aristarco V; Johansson H; Gandini S; Macis D; Zanzottera C; Tolva G; Feroce I; Accornero C; Bonanni B; Guerrieri-Gonzaga A; Serrano D
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917614
[TBL] [Abstract][Full Text] [Related]
19. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer.
Francis I; AlAbdali N; Kapila K; John B; Al-Temaimi RA
Int J Vitam Nutr Res; 2021 Jan; 91(1-2):124-132. PubMed ID: 31623531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
